reported novel amino‐ionizable‐lipid‐based lipid nanoparticles to effectively deliver Cas9 mRNA and sgRNA to knock out the PLK1 gene in vivo in an orthotropic glioma model. This evidence concerns the gene PLK1 and glioma.